Mudra Sikenis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mudra Sikenis has a total of 61 co-authors. Here are the top co-authors by number of shared publications:
- Ashutosh Kumar Singh
School of Biosciences, Engineering and Technology, VIT Bhopal University, Sehore 466114, India
7 shared publications Bhavna Prajapati
6 shared publications- Ram Kumar Nema
Division of Environmental Biotechnology, Genetics and Molecular Biology, ICMR - National Institute for Research in Environmental Health, Bhopal, 462 030, India.
3 shared publications - Ram Kumar Nema
Division of Environmental Biotechnology Genetics and Molecular Biology, ICMR—National Institute for Research in Environmental Health, Bhopal 462030, India
3 shared publications Surya Singh
Division of Environmental Monitoring and Exposure Assessment (Water & Soil), ICMR - National Institute for Research in Environmental Health, Bhopal, 462 030, India
3 shared publicationsVishal Diwan
Division of Environmental Monitoring and Exposure Assessment (Water & Soil), ICMR - National Institute for Research in Environmental Health, Bhopal, 462 030, India
3 shared publications
Latest Publications
- 16 September 2026
- Published by Bentham Science Publishers Ltd. in Current Drug Discovery Technologies
- Vol. 23, 1-22
Exploration of Bacopa monnieri–derived Green Ligands for Targeted IDH1 Inhibition in Glioblastoma
Background: Sustainable drug discovery is an emerging paradigm in biomedicine driven by green chemistry principles, which allow mindful utilization of favorable renewable biological scaffolds and energy-efficient computational strategies. Plant-derived phytochemicals represent an ecologically reliable alternative to conventional synthetic drug libraries, consistent with the principles of low-carbon use and resource-effective innovation. In this study, phytocompounds from Bacopa monnieri were screened against wild-type and mutant Isocitrate Dehydrogenase 1 (IDH1), which is a key enzyme involved in glioblastoma pathogenesis. Method: This study employed a comprehensive, multi-layered computational approach comprising Protein-Protein Interaction (PPI) networks and Gene Ontology (GO) annotations, KEGG pathway enrichment, molecular docking, ADME profiling, and Molecular Dynamics (MD) simulations. Result: The network analysis revealed that IDH1, IDH3A, IDH3B, CS, and OGDH were identified as major regulators of oncogenic metabolic pathways. Further, enrichment analysis associated these proteins with key processes involved in tumor metabolism and redox regulation. Molecular docking identified Bacoside A2 as the most favorable compound with high affinity for wild-type and mutant IDH1’s catalytic residues, followed by Bacopaside VII. MD simulation studies confirmed that Bacoside A2 forms a stable, energetically favorable complex within the catalytic pocket, which remained consistent throughout the simulation. In addition to its potential medical applications, this computational based phytochemical study reflects the principles of green energy and green chemistry by combining renewable plant-based scaffolds with energy-efficient in silico techniques, thereby greatly reducing laboratory resource consumption. Discussion: The integrated system-level network analysis, combined with computational docking and molecular dynamics studies, supported the feasibility of using the renewable phytochemical scaffold, Bacoside A2, as a potential dual inhibitor of IDH1 in central nervous system tumors. Conclusion: Bacoside A2 emerges as a strong, nanotechnologically versatile phytocompound and a dual IDH1 inhibitor, with potential for use in the development of next-generation, natural product-based therapies against glioblastoma and other malignancies associated with IDH1.
- 16 September 2026
- Published by Bentham Science Publishers Ltd. in Current Drug Discovery Technologies
- Vol. 23, 1-22
Exploration of Bacopa monnieri–derived Green Ligands for Targeted IDH1 Inhibition in Glioblastoma
Background: Sustainable drug discovery is an emerging paradigm in biomedicine driven by green chemistry principles, which allow mindful utilization of favorable renewable biological scaffolds and energy-efficient computational strategies. Plant-derived phytochemicals represent an ecologically reliable alternative to conventional synthetic drug libraries, consistent with the principles of low-carbon use and resource-effective innovation. In this study, phytocompounds from Bacopa monnieri were screened against wild-type and mutant Isocitrate Dehydrogenase 1 (IDH1), which is a key enzyme involved in glioblastoma pathogenesis. Method: This study employed a comprehensive, multi-layered computational approach comprising Protein-Protein Interaction (PPI) networks and Gene Ontology (GO) annotations, KEGG pathway enrichment, molecular docking, ADME profiling, and Molecular Dynamics (MD) simulations. Result: The network analysis revealed that IDH1, IDH3A, IDH3B, CS, and OGDH were identified as major regulators of oncogenic metabolic pathways. Further, enrichment analysis associated these proteins with key processes involved in tumor metabolism and redox regulation. Molecular docking identified Bacoside A2 as the most favorable compound with high affinity for wild-type and mutant IDH1’s catalytic residues, followed by Bacopaside VII. MD simulation studies confirmed that Bacoside A2 forms a stable, energetically favorable complex within the catalytic pocket, which remained consistent throughout the simulation. In addition to its potential medical applications, this computational based phytochemical study reflects the principles of green energy and green chemistry by combining renewable plant-based scaffolds with energy-efficient in silico techniques, thereby greatly reducing laboratory resource consumption. Discussion: The integrated system-level network analysis, combined with computational docking and molecular dynamics studies, supported the feasibility of using the renewable phytochemical scaffold, Bacoside A2, as a potential dual inhibitor of IDH1 in central nervous system tumors. Conclusion: Bacoside A2 emerges as a strong, nanotechnologically versatile phytocompound and a dual IDH1 inhibitor, with potential for use in the development of next-generation, natural product-based therapies against glioblastoma and other malignancies associated with IDH1.
- Open Access
Decoding Norovirus Biology: Insights into Epidemiology, Structural Dynamics, Host Interactions, and Viral Replication
Norovirus is the leading cause of acute infectious gastroenteritis in the world and accounts for a significant proportion of outbreaks at the food-borne and person-to-person levels. Due to their low infectious dose, persistence in the environment, and broad genetic diversity, they can quickly spread and reappear in even the most diverse populations. This review integrates current knowledge on the epidemiology of noroviruses, genomic organization, structural biology, virus–host interactions, and replication mechanisms, with a focus on factors that determine virus evolution and strain dominance. Literature has been systematically searched in the PubMed and Scopus databases to incorporate recent experimental and epidemiological findings. Analysis of global surveillance data indicates ongoing genetic diversification of circulating strains, with periodic replacement of major variants, particularly the GII.4 lineage. Variability of the capsid and recognition of histo-blood Group Antigens strongly affects the host’s susceptibility, viral attachment and immune escape. The capsid consists of most of the viral protein complexes. The structural proteins VP1 and VP2 are responsible for determining the contours of the capsid and antigenic specificity. Non-structural proteins are responsible for coordinating the genome replication and the modification of host cell pathways to favor the production of the virus. Eliminating these gaps by means of integrated genomic surveillance and functional studies will provide insight into the evolution of norovirus and help to develop broadly effective vaccines and antiviral strategies.
Open AccessDecoding Norovirus Biology: Insights into Epidemiology, Structural Dynamics, Host Interactions, and Viral Replication
Norovirus is the leading cause of acute infectious gastroenteritis in the world and accounts for a significant proportion of outbreaks at the food-borne and person-to-person levels. Due to their low infectious dose, persistence in the environment, and broad genetic diversity, they can quickly spread and reappear in even the most diverse populations. This review integrates current knowledge on the epidemiology of noroviruses, genomic organization, structural biology, virus–host interactions, and replication mechanisms, with a focus on factors that determine virus evolution and strain dominance. Literature has been systematically searched in the PubMed and Scopus databases to incorporate recent experimental and epidemiological findings. Analysis of global surveillance data indicates ongoing genetic diversification of circulating strains, with periodic replacement of major variants, particularly the GII.4 lineage. Variability of the capsid and recognition of histo-blood Group Antigens strongly affects the host’s susceptibility, viral attachment and immune escape. The capsid consists of most of the viral protein complexes. The structural proteins VP1 and VP2 are responsible for determining the contours of the capsid and antigenic specificity. Non-structural proteins are responsible for coordinating the genome replication and the modification of host cell pathways to favor the production of the virus. Eliminating these gaps by means of integrated genomic surveillance and functional studies will provide insight into the evolution of norovirus and help to develop broadly effective vaccines and antiviral strategies.
- 10 April 2026
- Published by Springer Nature in Indian Journal of Gastroenterology
- Vol. 45 (6) , 1053-1067
Prevalence of astrovirus-associated gastroenteritis among hospitalized pediatric patients in Asia: A systematic review and meta-analysis
Viral gastroenteritis is a significant public health concern in developing countries, primarily affecting children under five years. Human astrovirus (HAstV) is one of the key viral agents causing gastroenteritis. Despite the global recognition of HAstV as a causative agent of acute gastroenteritis, its impact on Asian populations, particularly among hospitalized children, is lacking. This systematic review and meta-analysis aimed at determining the prevalence of HAstV-associated acute gastroenteritis among hospitalized pediatric patients in Asia. This systematic review and meta-analysis was conducted following PRISMA Guidelines and registered with PROSPERO (ID CRD42024519527). A comprehensive literature search was performed on PubMed, Web of Science and Scopus databases for studies published between January 2000 and December 2023. Keywords related to astrovirus, prevalence, pediatric populations and hospitalization in Asia were used. A pre-designed Excel sheet was used for data extraction and the Joanna Briggs Institute critical appraisal tool was used for quality assessment. Generalized Linear Mixed Models with logit transformation were used to calculate the effect sizes. The analysis included 49 studies, encompassing data from various Asian countries. The pooled prevalence of HAstV in hospitalized pediatric patients due to acute gastroenteritis was 2.39%, highlighting the significant burden in Asia. Sub-group analysis revealed considerable difference in HAstV prevalence among Asian countries. This systematic review and meta-analysis summarizes the prevalence of HAstV among hospitalized pediatric patients in Asia, highlighting the need for country-specific strategies to improve surveillance and diagnostics.
- 10 April 2026
- Published by Springer Nature in Indian Journal of Gastroenterology
- Vol. 45 (6) , 1053-1067
Prevalence of astrovirus-associated gastroenteritis among hospitalized pediatric patients in Asia: A systematic review and meta-analysis
Viral gastroenteritis is a significant public health concern in developing countries, primarily affecting children under five years. Human astrovirus (HAstV) is one of the key viral agents causing gastroenteritis. Despite the global recognition of HAstV as a causative agent of acute gastroenteritis, its impact on Asian populations, particularly among hospitalized children, is lacking. This systematic review and meta-analysis aimed at determining the prevalence of HAstV-associated acute gastroenteritis among hospitalized pediatric patients in Asia. This systematic review and meta-analysis was conducted following PRISMA Guidelines and registered with PROSPERO (ID CRD42024519527). A comprehensive literature search was performed on PubMed, Web of Science and Scopus databases for studies published between January 2000 and December 2023. Keywords related to astrovirus, prevalence, pediatric populations and hospitalization in Asia were used. A pre-designed Excel sheet was used for data extraction and the Joanna Briggs Institute critical appraisal tool was used for quality assessment. Generalized Linear Mixed Models with logit transformation were used to calculate the effect sizes. The analysis included 49 studies, encompassing data from various Asian countries. The pooled prevalence of HAstV in hospitalized pediatric patients due to acute gastroenteritis was 2.39%, highlighting the significant burden in Asia. Sub-group analysis revealed considerable difference in HAstV prevalence among Asian countries. This systematic review and meta-analysis summarizes the prevalence of HAstV among hospitalized pediatric patients in Asia, highlighting the need for country-specific strategies to improve surveillance and diagnostics.
- Open Access
- 25 March 2026
- Published by Baishideng Publishing Group Inc. in World Journal of Virology
- Vol. 15 (1)
Prevalence of sapovirus infection among hospitalized pediatric patients in Asia: A systematic review and meta-analysis
BACKGROUND Acute gastroenteritis significantly affects children under five, with viral agents causing over 75% of cases. Sapovirus, from the Caliciviridae family, is increasingly recognized as a major cause of childhood diarrhea, especially in low and middle-income countries with high morbidity, hospitalization, and mortality rates. AIM To determine the prevalence of sapovirus infection among hospitalized pediatric patients in Asia. METHODS This study conducted a systematic review to investigate the presence of sapovirus in hospitalised pediatric patients suffering from acute gastroenteritis across Asian countries. The articles were retrieved from Scopus, PubMed, and Web of Science. The review followed PRISMA guidelines and was registered with PROSPERO (No. CRD420251029792). The quality of individual studies was assessed using Joanna Briggs Institute guidelines. RESULTS A total of 39 studies with 30800 observations and 567 sapovirus-positive cases were analyzed. The pooled prevalence of sapovirus in hospitalized pediatric patients was 1.73% (95% confidence interval: 1.33%-2.25%). Substantial heterogeneity was observed (I 2 = 84.9%), supporting the use of a random-effects model. Sensitivity analysis using 32 high-quality studies yielded a consistent prevalence of 1.74% (95% confidence interval: 1.31%-2.31%), reinforcing the robustness of the findings. CONCLUSION In Asian countries, sapovirus has been detected in hospitalized pediatric patients with a pooled prevalence rate of 1.73%, indicating its ongoing circulation and potential public health relevance in the region. Despite variability, consistent findings from sensitivity analysis underscore the need for enhanced surveillance and water quality monitoring to reduce public health risks.
- 25 March 2026
- Published by Baishideng Publishing Group Inc. in World Journal of Virology
- Vol. 15 (1)
Open AccessPrevalence of sapovirus infection among hospitalized pediatric patients in Asia: A systematic review and meta-analysis
BACKGROUND Acute gastroenteritis significantly affects children under five, with viral agents causing over 75% of cases. Sapovirus, from the Caliciviridae family, is increasingly recognized as a major cause of childhood diarrhea, especially in low and middle-income countries with high morbidity, hospitalization, and mortality rates. AIM To determine the prevalence of sapovirus infection among hospitalized pediatric patients in Asia. METHODS This study conducted a systematic review to investigate the presence of sapovirus in hospitalised pediatric patients suffering from acute gastroenteritis across Asian countries. The articles were retrieved from Scopus, PubMed, and Web of Science. The review followed PRISMA guidelines and was registered with PROSPERO (No. CRD420251029792). The quality of individual studies was assessed using Joanna Briggs Institute guidelines. RESULTS A total of 39 studies with 30800 observations and 567 sapovirus-positive cases were analyzed. The pooled prevalence of sapovirus in hospitalized pediatric patients was 1.73% (95% confidence interval: 1.33%-2.25%). Substantial heterogeneity was observed (I 2 = 84.9%), supporting the use of a random-effects model. Sensitivity analysis using 32 high-quality studies yielded a consistent prevalence of 1.74% (95% confidence interval: 1.31%-2.31%), reinforcing the robustness of the findings. CONCLUSION In Asian countries, sapovirus has been detected in hospitalized pediatric patients with a pooled prevalence rate of 1.73%, indicating its ongoing circulation and potential public health relevance in the region. Despite variability, consistent findings from sensitivity analysis underscore the need for enhanced surveillance and water quality monitoring to reduce public health risks.
- Open Access
- 22 January 2026
- Published by Elsevier in In Silico Research in Biomedicine
- Vol. 2
Potentiality of phytocompounds from Kalanchoe pinnata as an antibiofilm inhibitor of ESKAPE pathogens: A computational approach
- 22 January 2026
- Published by Elsevier in In Silico Research in Biomedicine
- Vol. 2
Open AccessPotentiality of phytocompounds from Kalanchoe pinnata as an antibiofilm inhibitor of ESKAPE pathogens: A computational approach
- Open Access
- 30 December 2025
- Published by Wolters Kluwer Health in Journal of Family Medicine and Primary Care
- Vol. 14 (12) , 4940-4947
The impact of variations in the chikungunya genome on the clinical manifestations and transmission of the disease
A BSTRACT: The Chikungunya virus (CHIKV) has emerged as a public health concern around the world as they have large epidemics. These epidemics are associated not just with mild but also with severe clinical manifestations. CHIKV was first discovered in Tanzania in 1952. Because of climate change, urbanization, and international travel, it has expanded. The rising incidence of diseases primarily transmitted by Aedes aegypti and Aedes albopictus mosquitoes highlights the urgent need for better surveillance, vector control, and therapeutics. CHIKV is an RNA virus that mutates frequently leading to genetic diversity and complicating disease management. In this review, we present how genomic variations of CHIKV can affect clinical presentation and transmission dynamics. We discuss the mutations in CHIKV that were analyzed in various outbreaks. We examine the structural and lifecycle characteristics of CHIKV, followed by a detailed exploration of important genomic modifications in structural (E1, E2) and nonstructural (nsP3) proteins, and their consequences for viral propagation, immune evasion, and pathogenicity. Mutations in the E1 protein, for instance, enhance entry into host cells, while mutations in the E2 protein reduce antibody neutralization. Changes in nsP3 are connected to more replication and disease problems. It is difficult to diagnose, treat, and make vaccines for them. The continuous genetic monitoring of viruses is important to check the new variants that are emerging. A comprehensive approach including better diagnostics, selective vector control, vaccine development, and community-based management would help mitigate CHIKV impact. Through illuminating the link between viral evolution and clinical outcomes, the current review aims to stimulate future research and reinforce preparedness against this ever-evolving virus.
- 30 December 2025
- Published by Wolters Kluwer Health in Journal of Family Medicine and Primary Care
- Vol. 14 (12) , 4940-4947
Open AccessThe impact of variations in the chikungunya genome on the clinical manifestations and transmission of the disease
A BSTRACT: The Chikungunya virus (CHIKV) has emerged as a public health concern around the world as they have large epidemics. These epidemics are associated not just with mild but also with severe clinical manifestations. CHIKV was first discovered in Tanzania in 1952. Because of climate change, urbanization, and international travel, it has expanded. The rising incidence of diseases primarily transmitted by Aedes aegypti and Aedes albopictus mosquitoes highlights the urgent need for better surveillance, vector control, and therapeutics. CHIKV is an RNA virus that mutates frequently leading to genetic diversity and complicating disease management. In this review, we present how genomic variations of CHIKV can affect clinical presentation and transmission dynamics. We discuss the mutations in CHIKV that were analyzed in various outbreaks. We examine the structural and lifecycle characteristics of CHIKV, followed by a detailed exploration of important genomic modifications in structural (E1, E2) and nonstructural (nsP3) proteins, and their consequences for viral propagation, immune evasion, and pathogenicity. Mutations in the E1 protein, for instance, enhance entry into host cells, while mutations in the E2 protein reduce antibody neutralization. Changes in nsP3 are connected to more replication and disease problems. It is difficult to diagnose, treat, and make vaccines for them. The continuous genetic monitoring of viruses is important to check the new variants that are emerging. A comprehensive approach including better diagnostics, selective vector control, vaccine development, and community-based management would help mitigate CHIKV impact. Through illuminating the link between viral evolution and clinical outcomes, the current review aims to stimulate future research and reinforce preparedness against this ever-evolving virus.
- Open Access
- 31 December 2024
- Published by Scientific Scholar in Journal of Reproductive Healthcare and Medicine
- Vol. 5, 17
Genital tuberculosis: A silent contributor to infertility and adverse pregnancy outcomes
Genital tuberculosis (GTB) is a significant yet often unnoticed reason for infertility, disproportionately affecting women in areas with a high burden of tuberculosis (TB). Notwithstanding its considerable effect on reproductive health, GTB remains underdiagnosed due to its inconspicuous clinical presentation and the limits of existing diagnostic tools. This review gives a top-to-bottom examination of the epidemiological patterns and physiological impacts of GTB, featuring the intricate interchange between illness and infertility. The discussion envelops the complex difficulties in diagnosing GTB-associated infertility, which incorporate the nonspecific symptoms, the absence of delicate and explicit diagnostic tests, and the potential for misdiagnosis with other gynecological conditions. Furthermore, we investigate the ongoing pharmacological medications used to treat GTB, focusing on their efficacy, limitations, and the emergence of drug-resistant TB strains that complicate treatment outcomes.
- 31 December 2024
- Published by Scientific Scholar in Journal of Reproductive Healthcare and Medicine
- Vol. 5, 17
Open AccessGenital tuberculosis: A silent contributor to infertility and adverse pregnancy outcomes
Genital tuberculosis (GTB) is a significant yet often unnoticed reason for infertility, disproportionately affecting women in areas with a high burden of tuberculosis (TB). Notwithstanding its considerable effect on reproductive health, GTB remains underdiagnosed due to its inconspicuous clinical presentation and the limits of existing diagnostic tools. This review gives a top-to-bottom examination of the epidemiological patterns and physiological impacts of GTB, featuring the intricate interchange between illness and infertility. The discussion envelops the complex difficulties in diagnosing GTB-associated infertility, which incorporate the nonspecific symptoms, the absence of delicate and explicit diagnostic tests, and the potential for misdiagnosis with other gynecological conditions. Furthermore, we investigate the ongoing pharmacological medications used to treat GTB, focusing on their efficacy, limitations, and the emergence of drug-resistant TB strains that complicate treatment outcomes.
- Open Access
- 24 April 2024
- Published by Springer Nature in Cureus
- Vol. 16 (4) , e58882
Investigating the Presence of Rotavirus in Wastewater Samples of Bhopal Region, India, by Utilizing Droplet Digital Polymerase Chain Reaction
Introduction: Rotavirus-induced viral gastroenteritis outbreaks result in over two million hospitalizations globally yearly. Wastewater-based epidemiology (WBE) has emerged as a crucial tool for detecting and monitoring viral outbreaks. The adoption of WBE has been instrumental in the early detection and surveillance of such viral outbreaks, providing a non-invasive method to assess public health. Objective: This study aims to utilize droplet digital polymerase chain reaction (ddPCR) technology to detect and quantify Rotavirus in wastewater samples collected from the Bhopal region of India, thereby contributing to the understanding and management of viral gastroenteritis outbreaks through environmental surveillance. Methods: In this study, we used ddPCR to detect and quantify Rotavirus in wastewater samples collected from the Bhopal region of India. We monitored its viral presence in municipal sewage treatment plants bi-weekly using an advanced ddPCR assay. Targeting the rotavirus non-structural protein 3 (NSP-3) region with custom primers and TaqMan probes, we detected virus concentration employing polyethylene glycol (PEG). Following RNA isolation, complementary DNA (cDNA) synthesis, and ddPCR analysis, our novel method eliminated standard curve dependence, propelling virus research and treatment forward. Results: Out of the 42 samples collected, a 16.60% positivity rate was observed, indicating a moderate presence of Rotavirus in Bhopal. The wastewater treatment plants (WWTP) attached to a hospital exhibited a 42.85% positivity rate, indicating the need for targeted monitoring. Leveraging ddPCR, precise quantification of rotavirus concentrations (ranging from 0.75 to 28.9 copies/µL) facilitated understanding and supported effective remediation. Conclusions: This study emphasizes the importance of vigilant wastewater surveillance, especially in WWTPs with higher rotavirus prevalence. The significance of ddPCR in comparison to conventional and real-time PCR lies in its superior sensitivity and specificity in detecting and quantifying positive samples. Furthermore, it can identify positive samples even in the smallest quantities without the need for a standard curve to evaluate. This makes ddPCR a valuable tool for accurate and precise detection and quantification of samples.
- 24 April 2024
- Published by Springer Nature in Cureus
- Vol. 16 (4) , e58882
Open AccessInvestigating the Presence of Rotavirus in Wastewater Samples of Bhopal Region, India, by Utilizing Droplet Digital Polymerase Chain Reaction
Introduction: Rotavirus-induced viral gastroenteritis outbreaks result in over two million hospitalizations globally yearly. Wastewater-based epidemiology (WBE) has emerged as a crucial tool for detecting and monitoring viral outbreaks. The adoption of WBE has been instrumental in the early detection and surveillance of such viral outbreaks, providing a non-invasive method to assess public health. Objective: This study aims to utilize droplet digital polymerase chain reaction (ddPCR) technology to detect and quantify Rotavirus in wastewater samples collected from the Bhopal region of India, thereby contributing to the understanding and management of viral gastroenteritis outbreaks through environmental surveillance. Methods: In this study, we used ddPCR to detect and quantify Rotavirus in wastewater samples collected from the Bhopal region of India. We monitored its viral presence in municipal sewage treatment plants bi-weekly using an advanced ddPCR assay. Targeting the rotavirus non-structural protein 3 (NSP-3) region with custom primers and TaqMan probes, we detected virus concentration employing polyethylene glycol (PEG). Following RNA isolation, complementary DNA (cDNA) synthesis, and ddPCR analysis, our novel method eliminated standard curve dependence, propelling virus research and treatment forward. Results: Out of the 42 samples collected, a 16.60% positivity rate was observed, indicating a moderate presence of Rotavirus in Bhopal. The wastewater treatment plants (WWTP) attached to a hospital exhibited a 42.85% positivity rate, indicating the need for targeted monitoring. Leveraging ddPCR, precise quantification of rotavirus concentrations (ranging from 0.75 to 28.9 copies/µL) facilitated understanding and supported effective remediation. Conclusions: This study emphasizes the importance of vigilant wastewater surveillance, especially in WWTPs with higher rotavirus prevalence. The significance of ddPCR in comparison to conventional and real-time PCR lies in its superior sensitivity and specificity in detecting and quantifying positive samples. Furthermore, it can identify positive samples even in the smallest quantities without the need for a standard curve to evaluate. This makes ddPCR a valuable tool for accurate and precise detection and quantification of samples.
- 4 January 2024
- Published by Springer Nature
- p. 45-75
Synthesis of Biogenic Nanomaterials, Their Characterization, and Applications
- 4 January 2024
- Published by Springer Nature
- p. 45-75
Synthesis of Biogenic Nanomaterials, Their Characterization, and Applications